SLC16A1 and amyotrophic lateral sclerosis: A significant loss of oligodendrocytes in both ALS patients and presymptomatic ALS mice has been described [196,197], and in the surviving oligodendrocytes, a decreased expression of monocarboxylate transporter 1 (which is essential for oligodendrocytic trophic function) has been found.